Maintenance Zanzalintinib and Durvalumab in Participants With Advanced Hepatocellular Cancer
Clinical trial NCT07226063 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07226063
- Sponsor
- Amit Mahipal
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-05-01
- Primary completion
- 2028-02-01
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.